Please login to the form below

Not currently logged in
Email:
Password:

SOBI

This page shows the latest SOBI news and features for those working in and with pharma, biotech and healthcare.

NHS England says yes to Roche's Hemlibra

NHS England says yes to Roche's Hemlibra

a rarer form of the disease), Sobi’s Kineret (anakinra) for periodic fevers and autoinflammatory diseases and Amryt Pharma’s Lojuxta (lomitapide) for homozygous familial hypercholesterolaemia (HoFH).

Latest news

More from news
Approximately 5 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • A rare opportunity A rare opportunity

    A rare opportunity. Sobi’ s Neil Dugdale on how the UK’ s approach to rare diseases is changing. ... An exciting time. For Neil's company Sobi it's certainly been a busy time this year.

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • BMS appoints CCO, Stephen Davies joins Eisai and more BMS appoints CCO, Stephen Davies joins Eisai and more

    Sobi appoints head of technical operations. Rare disease specialist company Sobi has appointed Anne Marie de Jonge Schuermans to front its new technical operations organisation. ... operations. She joins Sobi from Biogen, where she served as vice

  • Sobi poaches Pfizer’s Fredrick Wetterlundh Sobi poaches Pfizer’s Fredrick Wetterlundh

    Sobi poaches Pfizer’ s Fredrick Wetterlundh. He joins the speciality healthcare group as head of human resources. ... Swedish Orphan Biovitrum (Sobi) has appointed Fredrik Wetterlundh as head of human resources and will simultaneously be part of

  • Mereo BioPharma appoints head of patient access and commercial planning Mereo BioPharma appoints head of patient access and commercial planning

    Mereo BioPharma appoints head of patient access and commercial planning. Wills Hughes-Wilson joins the group from Sobi. ... In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and led pricing, reimbursement and access

  • Sobi names Holly May VP of sales and marketing, US Sobi names Holly May VP of sales and marketing, US

    Rare disease firm Sobi has appointed Holly May as its new vice president of sales and marketing for the US. ... May’s new role will see her lead the biopharma’s commercial team in bringing Sobi ’s medicines to the country.

  • Relay Therapeutics appoints Sarah O’Brien as VP of HR Relay Therapeutics appoints Sarah O’Brien as VP of HR

    Relay Therapeutics appoints Sarah O’ Brien as VP of HR. She joins the biotech from Sobi. ... She joins the biotech from Sobi in North America, where she was responsible for a variety of global initiatives across learning, development and culture.

More from appointments
Approximately 9 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics